Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  BioNTech SE    BNTX

BIONTECH SE

(BNTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/15/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
101.59(c) 104.7(c) 103.23(c) 105.43(c) 108.44(c) Last
3 151 568 2 018 242 1 615 666 2 256 344 1 690 445 Volume
-4.02% +3.06% -1.40% +2.13% +2.85% Change
More quotes
Financials
Sales 2020 497 M 605 M 605 M
Net income 2020 -329 M -401 M -401 M
Net cash position 2020 936 M 1 139 M 1 139 M
P/E ratio 2020 -72,0x
Yield 2020 -
Sales 2021 6 507 M 7 918 M 7 918 M
Net income 2021 4 445 M 5 409 M 5 409 M
Net cash position 2021 4 339 M 5 281 M 5 281 M
P/E ratio 2021 5,77x
Yield 2021 -
Capitalization 21 455 M 26 111 M 26 108 M
EV / Sales 2020 41,3x
EV / Sales 2021 2,63x
Nbr of Employees 1 800
Free-Float 92,4%
More Financials
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer... 
More about the company
Notations Surperformance© of BioNTech SE
Trading Rating : Investor Rating :
More Ratings
All news about BIONTECH SE
01/22Pfizer to supply 40M COVID-19 shots for poor countries
AQ
01/22AstraZeneca Warns of Covid-19 Vaccine Shortfall in Europe -- Update
DJ
01/22AstraZeneca Warns of Covid-19 Vaccine Shortfall in Europe
DJ
01/22AstraZeneca's initial EU delivery volumes of COVID-19 vaccine to fall short
RE
01/22PFIZER : BioNTech Unveil Agreement for 40 Million Supply of Coronavirus Vaccines..
MT
01/22PFIZER : BioNTech in Vaccine Advance Purchase Agreement With Covax
DJ
01/22PRESS RELEASE : Pfizer and BioNTech Reach -2-
DJ
01/22PRESS RELEASE : Pfizer and BioNTech Reach Agreement with COVAX for Advance Purch..
DJ
01/22Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccin..
GL
01/22European ADRs Move Lower in Friday Trading
MT
01/22Where Our Current Covid-19 Vaccination Rate Will Take Us
DJ
01/22Studies of South African Coronavirus Strain Raise Concerns About Immune Respo..
DJ
01/22MARKET CHATTER : Pfizer, BioNTech Reportedly Agree to Supply Vaccine for WHO-Bac..
MT
01/22Poland says it could take legal action over Pfizer COVID-19 vaccine delay
RE
01/22BioNTech Partner Pfizer Halves COVID-19 Vaccine Deliveries to Some EU States
MT
More news
News in other languages on BIONTECH SE
12:02pCOVID-19 : des mesures plus strictes pour tenter d'éviter un 3e confinement
11:19aSPAHN : Im Februar mindestens drei Millionen Impfdosen von Astrazeneca
06:29aVACCINS/COVID-19 : les autorités de santé recommandent d'espacer de 6 semaines
04:48aPas de retard dans la campagne de vaccination française, assure Pannier-Runac..
03:16aCORONAVIRUS : à peine lancée, la vaccination au Brésil connaît des ratés
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 92,65 €
Last Close Price 89,10 €
Spread / Highest target 24,7%
Spread / Average Target 3,98%
Spread / Lowest Target -35,4%
EPS Revisions
Managers and Directors
NameTitle
Ugur Sahin Chief Executive Officer
Helmut Jeggle Chairman-Supervisory Board
Sierk Pötting Chief Operating & Financial Officer
Özlem Türeci Chief Medical Officer
Christoph Huber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BIONTECH SE33.02%26 111
GILEAD SCIENCES, INC.14.90%83 911
WUXI APPTEC CO., LTD.30.64%66 044
VERTEX PHARMACEUTICALS0.53%61 782
REGENERON PHARMACEUTICALS11.32%56 760
BEIGENE, LTD.44.94%34 148